M.J. Choi1, S. Gaikwad2, E. J. Kim3,4
, C.Y. Kim3,4, M.J. Kim1,2*
Muscle health is vital for quality of life in older adults, but those with
dysphagia often struggle to consume conventional protein or amino acid
supplements. To offer an easier-to-consume alternative, we developed orally
disintegrating films (ODFs) containing collagen hydrolysates (CH) from
pollock skin and citrus peel extract. Two variants were prepared with
leucine (0.5–1.0%) or β-hydroxy-β-methylbutyrate (HMB, 0.5–2.0%), designated
as CH/Leu and CH/HMB. The films displayed uniform structural properties
(thickness 0.21–0.27 mm; opacity 0.18–0.27) and rapidly disintegrated in the
mouth (CH/Leu: 10–14 s; CH/HMB: 13–18 s). Surface pH values (5.67–6.93) were
within physiologically acceptable limits.
Under simulated gastrointestinal conditions, both formulations showed
efficient intestinal release, reaching cumulative release rates of 98%
(CH/Leu) and 96% (CH/HMB). Release behavior fit well to the Kopcha (R² ≥
0.996) and Peleg (R² ≥ 0.999) models, indicating a diffusion-dominant
mechanism favorable for targeted nutrient delivery.
To further assess the muscle-supporting potential of the developed
ingredients, we evaluated the bioactivity of green tangerine–extracted
collagen (GEC) in C2C12 myoblasts. In a dexamethasone (DEX)-induced atrophy
model, DEX reduced myotube diameter by 36.6%, while leucine or HMB partially
restored it. Although GEC alone had minimal effect, co-treatment with GEC
(100 μg/mL) and HMB (50 μM) produced a synergistic increase in myotube
diameter that surpassed control levels. Immunofluorescence analysis showed
that MyHC expression suppressed by DEX was fully restored by the combined
treatment.
Western blot analysis supported these findings by showing that DEX
downregulated MyHC, mTOR, and p70S6K while increasing MuRF1 and Atrogin-1.
HMB partly reversed these changes, whereas GEC alone showed limited
activity. In contrast, co-treatment restored anabolic signaling markers and
reduced catabolic regulators to control or below-control levels. These
results indicate that GEC enhances HMB-mediated protection against muscle
atrophy by promoting anabolic pathways and suppressing muscle degradation.
Overall, CH-based ODFs enriched with leucine or HMB demonstrated favorable
physicochemical properties, rapid oral disintegration, efficient intestinal
release, and synergistic anti-atrophic effects when combined with GEC. These
films offer a safe and practical nutritional strategy to support muscle
health in older adults with dysphagia. Further studies should address
long-term safety, regulatory considerations, and clinical validation, and
explore optimized formulations or additional bioactives for personalized
muscle health applications.
Elsevier Competition